Midgard
Neurix

Neurix

Geneva, Switzerland neurix.ch From their website, Nov 2026

Work here? Claim this listing

About

Neurix develops human iPSC-based in vitro cellular and organoid models for drug discovery and neurotherapeutic research. It serves researchers working on brain diseases and preclinical compound testing from Geneva, Switzerland.

Neurix is based in Geneva, Switzerland, founded in 2011. It lists 15 services, including Glioblastoma Invasion Model, Blood-Brain Barrier Model and Alzheimer's Disease Model.

Services

  • Glioblastoma Invasion Model

    Glioblastoma-organoid assembloids used to assess drug efficiency on tumour growth, motility, and metastasis, and to test effects on healthy tissue using organoids.

  • Blood-Brain Barrier Model

    Transwell-based model seeded with iPSC-derived human brain microvascular endothelial cells to assess compound penetration efficiency.

  • Alzheimer's Disease Model

    Human organoid model with disease-specific readouts including morphology, protein aggregation, and beta-amyloid immunoreactivity.

  • Parkinson's Disease Model

    Human organoid model with disease-specific readouts including morphology, protein and alpha-synuclein aggregation.

  • Personalised Service

    Custom neural tissues from human stem cells, with bespoke disease models, assays, and in-depth omics analyses for drug discovery.

  • High throughput drug screening

    A personalised-service assay for screening compounds at higher throughput.

  • Lead compound validation

    A personalised-service method for validating lead compounds.

  • iPSCs differentiation

    Differentiation of induced pluripotent stem cells for personalised neural model development.

7 more services
  • Spheroid generation
  • 2D/3D imaging
  • 3D imaging
  • Immunohistochemistry/Immunofluorescence
  • Fluorescence-based assays
  • Flow cytometry
  • Genomics, Proteomics

How to order from Neurix

They take quote requests by email. You can contact them directly from this page, or request a quote through Midgard.

Capabilities

Assays and studies
  • Flow cytometry
  • Compound screening
  • Drug efficiency testing
  • Compound penetration testing
  • Morphology readouts
  • Protein aggregation readouts
12 more
  • Alpha-synuclein aggregation
  • High throughput drug screening
  • Lead compound validation
  • 2D imaging
  • 3D imaging
  • Immunohistochemistry
  • Immunofluorescence
  • Genomics
  • Proteomics
  • Drug screening
  • Compound testing
  • Fluorescence-based assays
Scale and capacity
  • High throughput
  • Short-term compound testing
  • Long-term compound testing
  • Highly physiological human 3-dimensional tissues
Therapeutic areas
  • Glioblastoma
  • Blood-brain barrier
  • Alzheimer's disease
  • Parkinson's disease
  • Neurodegenerative diseases
  • Brain disorders
3 more
  • Neuroscience
  • Neurotherapeutic research
  • Neuro-oncology

Instruments and platforms

  • Flow cytometry

Modalities and species

Modalities
Cell therapy
Species and models
  • Human iPSCs
  • Human brain microvascular endothelial cells
  • iPSCs-derived neurons
  • Astrocytes
  • Oligodendrocytes
  • BMEC
5 more
  • Cell line-derived spheroids
  • Patient-derived spheroids
  • Human
  • iPSC-derived human brain microvascular endothelial cells
  • Cell line or patient-derived spheroids

Industries served

  • Biotechnology
  • Pharmaceuticals
  • Neuroscience
  • Drug discovery

Details

Founded
2011
Based in
Geneva, Switzerland
Serves
Worldwide, Europe
Phone
+41 22 379 46 43

Similar labs